Daryl Faulkner, Chief Executive Officer of Digene Corporation, presides over the Market Open

Friday, January 12, 2007
at NASDAQ's MarketSite
in New York City.

Digene Corporation

Daryl Faulkner, Chief Executive Officer of Digene Corporation (DIGE), presides over the opening bell in honor of "Cervical Cancer Screening Month."

A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests with a focus on women's health. The company's flagship product, The Digene(r) HPV Test is the only FDA-approved test for the human papillomavirus (HPV), the cause of cervical cancer. Rapidly emerging as a standard of practice in cervical cancer screening, the HPV test aids healthcare professionals in identifying women who are most at risk of having or developing cervical cancer, which today is the world's second-most-common type of cancer affecting women. Digene's product portfolio also includes DNA tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Through its own staff or affiliated distributors, Digene markets its tests in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 01/12/2007 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Daryl Faulkner, Chief Executive Officer of Digene Corporation, Rings The NASDAQ Stock Market Open Bell. These photos are Copyright 2007, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2007, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.